{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T01:21:15Z","timestamp":1789176075906,"version":"build-2803163510"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,12,23]],"date-time":"2024-12-23T00:00:00Z","timestamp":1734912000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,12,23]],"date-time":"2024-12-23T00:00:00Z","timestamp":1734912000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"DOI":"10.1186\/s12967-024-05976-0","type":"journal-article","created":{"date-parts":[[2024,12,23]],"date-time":"2024-12-23T11:57:39Z","timestamp":1734955059000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Integration of Graph Neural Networks and multi-omics analysis identify the predictive factor and key gene for immunotherapy response and prognosis of bladder cancer"],"prefix":"10.1186","volume":"22","author":[{"given":"Shuai","family":"Ren","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongjian","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangping","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danni","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangna","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7834-9646","authenticated-orcid":false,"given":"Maodong","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,12,23]]},"reference":[{"issue":"2","key":"5976_CR1","doi-asserted-by":"publisher","first-page":"300060523115332","DOI":"10.1177\/03000605231153323","volume":"51","author":"JA Al-Maghrabi","year":"2023","unstructured":"Al-Maghrabi JA, Khabaz MN. Clinical significance of galectin-3 expression in urinary bladder carcinoma. J Int Med Res. 2023;51(2):3000605231153323.","journal-title":"J Int Med Res"},{"issue":"3","key":"5976_CR2","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1111\/bju.15661","volume":"130","author":"N Lobo","year":"2022","unstructured":"Lobo N, et al. Reduced-dose bacillus Calmette-Guerin (BCG) in an era of BCG shortage: real-world experience from a tertiary cancer centre. BJU Int. 2022;130(3):323\u201330.","journal-title":"BJU Int"},{"key":"5976_CR3","first-page":"8493519","volume":"2022","author":"S Liu","year":"2022","unstructured":"Liu S, et al. Neoadjuvant chemotherapy for different stages of muscle-invasive bladder cancer: a systematic review and meta-analysis. Dis Markers. 2022;2022:8493519.","journal-title":"Dis Markers"},{"issue":"1","key":"5976_CR4","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.urolonc.2020.10.006","volume":"41","author":"DM Girardi","year":"2023","unstructured":"Girardi DM, et al. Systemic therapy in bladder preservation. Urol Oncol. 2023;41(1):39\u201347.","journal-title":"Urol Oncol"},{"issue":"21","key":"5976_CR5","doi-asserted-by":"publisher","first-page":"2291","DOI":"10.1080\/15384101.2021.1982494","volume":"20","author":"X Chen","year":"2021","unstructured":"Chen X, et al. Pan-cancer analysis indicates that MYBL2 is associated with the prognosis and immunotherapy of multiple cancers as an oncogene. Cell Cycle. 2021;20(21):2291\u2013308.","journal-title":"Cell Cycle"},{"issue":"7","key":"5976_CR6","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.urolonc.2018.11.015","volume":"40","author":"JB da Costa","year":"2022","unstructured":"da Costa JB, et al. Molecular tumor heterogeneity in muscle invasive bladder cancer: biomarkers, subtypes, and implications for therapy. Urol Oncol. 2022;40(7):287\u201394.","journal-title":"Urol Oncol"},{"issue":"8","key":"5976_CR7","doi-asserted-by":"publisher","first-page":"7398","DOI":"10.3390\/curroncol30080536","volume":"30","author":"G Hui","year":"2023","unstructured":"Hui G, et al. Do cancer genetics impact treatment decision making? Immunotherapy and beyond in the management of advanced and metastatic urothelial carcinoma. Curr Oncol. 2023;30(8):7398\u2013411.","journal-title":"Curr Oncol"},{"issue":"13","key":"5976_CR8","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1056\/NEJMoa2002788","volume":"383","author":"T Powles","year":"2020","unstructured":"Powles T, et al. Avelumab maintenance therapy for advanced or metastatic urothelial carcinoma. N Engl J Med. 2020;383(13):1218\u201330.","journal-title":"N Engl J Med"},{"key":"5976_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.euo.2023.11.001","author":"M Kardoust Parizi","year":"2023","unstructured":"Kardoust Parizi M, et al. Metastatic organotropism differential treatment response in urothelial carcinoma: a systematic review and network meta-analysis of randomized controlled trials. Eur Urol Oncol. 2023. https:\/\/doi.org\/10.1016\/j.euo.2023.11.001.","journal-title":"Eur Urol Oncol"},{"key":"5976_CR10","doi-asserted-by":"publisher","DOI":"10.1109\/TPAMI.2022.3209686","author":"A Bessadok","year":"2022","unstructured":"Bessadok A, Mahjoub MA, Rekik I. Graph neural networks in network neuroscience. IEEE Trans Pattern Anal Mach Intell. 2022. https:\/\/doi.org\/10.1109\/TPAMI.2022.3209686.","journal-title":"IEEE Trans Pattern Anal Mach Intell"},{"key":"5976_CR11","doi-asserted-by":"publisher","DOI":"10.1093\/bib\/bbab432","author":"W Peng","year":"2022","unstructured":"Peng W, et al. Improving cancer driver gene identification using multi-task learning on graph convolutional network. Brief Bioinform. 2022. https:\/\/doi.org\/10.1093\/bib\/bbab432.","journal-title":"Brief Bioinform"},{"issue":"5","key":"5976_CR12","doi-asserted-by":"publisher","first-page":"2210","DOI":"10.1007\/s10278-023-00848-3","volume":"36","author":"R Josphineleela","year":"2023","unstructured":"Josphineleela R, et al. A multi-stage faster RCNN-based iSPLInception for skin disease classification using novel optimization. J Digit Imaging. 2023;36(5):2210\u201326.","journal-title":"J Digit Imaging"},{"key":"5976_CR13","doi-asserted-by":"publisher","DOI":"10.3390\/cancers16010181","author":"N Mohamed","year":"2023","unstructured":"Mohamed N, et al. Automated laryngeal cancer detection and classification using dwarf mongoose optimization algorithm with deep learning. Cancers (Basel). 2023. https:\/\/doi.org\/10.3390\/cancers16010181.","journal-title":"Cancers (Basel)"},{"key":"5976_CR14","doi-asserted-by":"publisher","DOI":"10.3390\/biomimetics8060499","author":"M Badawy","year":"2023","unstructured":"Badawy M, et al. Revolutionizing oral cancer detection: an approach using aquila and gorilla algorithms optimized transfer learning-based CNNs. Biomimetics (Basel). 2023. https:\/\/doi.org\/10.3390\/biomimetics8060499.","journal-title":"Biomimetics (Basel)"},{"issue":"1","key":"5976_CR15","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1186\/s12859-022-04950-1","volume":"23","author":"B Liang","year":"2022","unstructured":"Liang B, et al. Risk stratification and pathway analysis based on graph neural network and interpretable algorithm. BMC Bioinformatics. 2022;23(1):394.","journal-title":"BMC Bioinformatics"},{"issue":"5","key":"5976_CR16","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1089\/omi.2011.0118","volume":"16","author":"G Yu","year":"2012","unstructured":"Yu G, et al. clusterProfiler: an R package for comparing biological themes among gene clusters. OMICS. 2012;16(5):284\u20137.","journal-title":"OMICS"},{"issue":"6","key":"5976_CR17","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1016\/j.ccell.2021.04.014","volume":"39","author":"A Bagaev","year":"2021","unstructured":"Bagaev A, et al. Conserved pan-cancer microenvironment subtypes predict response to immunotherapy. Cancer Cell. 2021;39(6):845-865 e7.","journal-title":"Cancer Cell"},{"key":"5976_CR18","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1016\/j.csbj.2020.03.007","volume":"18","author":"L Li","year":"2020","unstructured":"Li L, Feng Q, Wang X. PreMSIm: an R package for predicting microsatellite instability from the expression profiling of a gene panel in cancer. Comput Struct Biotechnol J. 2020;18:668\u201375.","journal-title":"Comput Struct Biotechnol J"},{"issue":"2","key":"5976_CR19","doi-asserted-by":"publisher","first-page":"193","DOI":"10.21037\/tau-23-422","volume":"13","author":"W Meng","year":"2024","unstructured":"Meng W, et al. Reliable prognostic definition and immunotherapy response prediction in bladder cancer, based on a novel aging-associated 5-gene signature model. Transl Androl Urol. 2024;13(2):193\u2013208.","journal-title":"Transl Androl Urol"},{"issue":"1","key":"5976_CR20","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s12943-024-01945-9","volume":"23","author":"T Xie","year":"2024","unstructured":"Xie T, et al. Multi-cohort validation of Ascore: an anoikis-based prognostic signature for predicting disease progression and immunotherapy response in bladder cancer. Mol Cancer. 2024;23(1):30.","journal-title":"Mol Cancer"},{"key":"5976_CR21","doi-asserted-by":"publisher","first-page":"1365683","DOI":"10.3389\/fphar.2024.1365683","volume":"15","author":"X Peng","year":"2024","unstructured":"Peng X, et al. IL4I1: a novel molecular biomarker represents an inflamed tumor microenvironment and precisely predicts the molecular subtype and immunotherapy response of bladder cancer. Front Pharmacol. 2024;15:1365683.","journal-title":"Front Pharmacol"},{"key":"5976_CR22","doi-asserted-by":"publisher","first-page":"1326509","DOI":"10.3389\/fimmu.2023.1326509","volume":"14","author":"X Shi","year":"2023","unstructured":"Shi X, et al. Overexpression of MTHFD2 represents an inflamed tumor microenvironment and precisely predicts the molecular subtype and immunotherapy response of bladder cancer. Front Immunol. 2023;14:1326509.","journal-title":"Front Immunol"},{"issue":"11","key":"5976_CR23","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1038\/nm.3394","volume":"19","author":"DF Quail","year":"2013","unstructured":"Quail DF, Joyce JA. Microenvironmental regulation of tumor progression and metastasis. Nat Med. 2013;19(11):1423\u201337.","journal-title":"Nat Med"},{"issue":"8","key":"5976_CR24","doi-asserted-by":"publisher","first-page":"321","DOI":"10.46883\/ONC.3408.321","volume":"34","author":"S Darabi","year":"2020","unstructured":"Darabi S, et al. Predictive biomarkers for immunotherapy response beyond PD-1\/PD-L1. Oncology (Williston Park). 2020;34(8):321\u20137.","journal-title":"Oncology (Williston Park)"},{"key":"5976_CR25","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.915662","volume":"12","author":"WW Shi","year":"2022","unstructured":"Shi WW, et al. Integrative transcriptional characterization of cell cycle checkpoint genes promotes clinical management and precision medicine in bladder carcinoma. Front Oncol. 2022;12: 915662.","journal-title":"Front Oncol"},{"issue":"2","key":"5976_CR26","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1084\/jem.20140559","volume":"212","author":"T Voron","year":"2015","unstructured":"Voron T, et al. VEGF-A modulates expression of inhibitory checkpoints on CD8+ T cells in tumors. J Exp Med. 2015;212(2):139\u201348.","journal-title":"J Exp Med"},{"key":"5976_CR27","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21124414","author":"G Giannone","year":"2020","unstructured":"Giannone G, et al. Immuno-metabolism and microenvironment in cancer: key players for immunotherapy. Int J Mol Sci. 2020. https:\/\/doi.org\/10.3390\/ijms21124414.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"5976_CR28","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1038\/s41590-018-0265-1","volume":"20","author":"Y Wang","year":"2019","unstructured":"Wang Y, et al. The IL-15-AKT-XBP1s signaling pathway contributes to effector functions and survival in human NK cells. Nat Immunol. 2019;20(1):10\u20137.","journal-title":"Nat Immunol"},{"issue":"6","key":"5976_CR29","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1016\/j.immuni.2012.04.006","volume":"36","author":"K Ramirez","year":"2012","unstructured":"Ramirez K, et al. Gene deregulation and chronic activation in natural killer cells deficient in the transcription factor ETS1. Immunity. 2012;36(6):921\u201332.","journal-title":"Immunity"},{"issue":"1","key":"5976_CR30","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.bbrc.2018.09.102","volume":"505","author":"SY Zhu","year":"2018","unstructured":"Zhu SY, et al. miR-20a inhibits the killing effect of natural killer cells to cervical cancer cells by downregulating RUNX1. Biochem Biophys Res Commun. 2018;505(1):309\u201316.","journal-title":"Biochem Biophys Res Commun"},{"issue":"Pt A","key":"5976_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2022.109332","volume":"113","author":"H Won Jun","year":"2022","unstructured":"Won Jun H, et al. The role of CCL2, CCL7, ICAM-1, and VCAM-1 in interaction of endothelial cells and natural killer cells. Int Immunopharmacol. 2022;113(Pt A): 109332.","journal-title":"Int Immunopharmacol"},{"key":"5976_CR32","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.751834","volume":"11","author":"Y Xiao","year":"2021","unstructured":"Xiao Y, et al. Acute myeloid leukemia epigenetic immune escape from nature killer cells by ICAM-1. Front Oncol. 2021;11: 751834.","journal-title":"Front Oncol"},{"issue":"5","key":"5976_CR33","first-page":"3845","volume":"18","author":"J Zang","year":"2019","unstructured":"Zang J, et al. Senescent hepatocytes enhance natural killer cell activity via the CXCL-10\/CXCR3 axis. Exp Ther Med. 2019;18(5):3845\u201352.","journal-title":"Exp Ther Med"},{"key":"5976_CR34","doi-asserted-by":"publisher","first-page":"387","DOI":"10.2147\/ITT.S306109","volume":"10","author":"S Karmakar","year":"2021","unstructured":"Karmakar S, Pal P, Lal G. Key activating and inhibitory ligands involved in the mobilization of natural killer cells for cancer immunotherapies. Immunotargets Ther. 2021;10:387\u2013407.","journal-title":"Immunotargets Ther"},{"key":"5976_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2023.216466","volume":"581","author":"X Hu","year":"2024","unstructured":"Hu X, et al. Deciphering the tumor-suppressive role of PSMB9 in melanoma through multi-omics and single-cell transcriptome analyses. Cancer Lett. 2024;581: 216466.","journal-title":"Cancer Lett"},{"issue":"1","key":"5976_CR36","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1038\/s41598-023-28940-2","volume":"13","author":"K Geoffroy","year":"2023","unstructured":"Geoffroy K, et al. Increased expression of the immunoproteasome subunits PSMB8 and PSMB9 by cancer cells correlate with better outcomes for triple-negative breast cancers. Sci Rep. 2023;13(1):2129.","journal-title":"Sci Rep"},{"key":"5976_CR37","doi-asserted-by":"publisher","first-page":"9960905","DOI":"10.1155\/2021\/9960905","volume":"2021","author":"Q Pan","year":"2021","unstructured":"Pan Q, Cheng Y, Cheng D. Identification of CD8+ T cell-related genes: correlations with immune phenotypes and outcomes of liver cancer. J Immunol Res. 2021;2021:9960905.","journal-title":"J Immunol Res"},{"issue":"1","key":"5976_CR38","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1038\/s41467-020-14639-9","volume":"11","author":"S Kalaora","year":"2020","unstructured":"Kalaora S, et al. Immunoproteasome expression is associated with better prognosis and response to checkpoint therapies in melanoma. Nat Commun. 2020;11(1):896.","journal-title":"Nat Commun"},{"key":"5976_CR39","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.553399","volume":"10","author":"Y Wang","year":"2020","unstructured":"Wang Y, et al. CD8+ T cell co-expressed genes correlate with clinical phenotype and microenvironments of urothelial cancer. Front Oncol. 2020;10: 553399.","journal-title":"Front Oncol"},{"key":"5976_CR40","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.00615-17","author":"G Guimaraes","year":"2018","unstructured":"Guimaraes G, et al. Immunoproteasome subunits are required for CD8(+) T cell function and host resistance to brucella abortus infection in mice. Infect Immun. 2018. https:\/\/doi.org\/10.1128\/IAI.00615-17.","journal-title":"Infect Immun"},{"issue":"3","key":"5976_CR41","volume":"15","author":"NA Elhawary","year":"2023","unstructured":"Elhawary NA, et al. Sequence variants in PSMB8\/PSMB9 immunoproteasome genes and risk of urothelial bladder carcinoma. Cureus. 2023;15(3): e36293.","journal-title":"Cureus"},{"key":"5976_CR42","doi-asserted-by":"publisher","DOI":"10.1101\/2023.12.30.573739","author":"S Shimonov","year":"2024","unstructured":"Shimonov S, et al. SORBET: Automated cell-neighborhood analysis of spatial transcriptomics or proteomics for interpretable sample classification via GNN. bioRxiv. 2024. https:\/\/doi.org\/10.1101\/2023.12.30.573739.","journal-title":"bioRxiv"},{"issue":"5","key":"5976_CR43","doi-asserted-by":"publisher","first-page":"554","DOI":"10.2174\/0929867330666230403100008","volume":"31","author":"S Talluri","year":"2024","unstructured":"Talluri S, Kamal MA, Malla RR. Novel computational methods for cancer drug design. Curr Med Chem. 2024;31(5):554\u201372.","journal-title":"Curr Med Chem"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-024-05976-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-024-05976-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-024-05976-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,23]],"date-time":"2024-12-23T12:04:33Z","timestamp":1734955473000},"score":1,"resource":{"primary":{"URL":"https:\/\/translational-medicine.biomedcentral.com\/articles\/10.1186\/s12967-024-05976-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,23]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["5976"],"URL":"https:\/\/doi.org\/10.1186\/s12967-024-05976-0","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,23]]},"assertion":[{"value":"7 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 December 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors have consent for publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1141"}}